New anti-tuberculosis drugs in clinical development: an overview

J Guillemont, F Lieby-Muller, N Lounis… - Current Bioactive …, 2009 - ingentaconnect.com
Tuberculosis (TB) remains one of the most deadly infectious diseases in the world, killing
about 2 million people per year, and mostly affecting the world's poorest population. The …

New anti-tuberculosis drugs in clinical development: an overview

J Guillemont, F Lieby-Muller… - Current bioactive …, 2009 - repository.uantwerpen.be
Tuberculosis (TB) remains one of the most deadly infectious diseases in the world, killing
about 2 million people per year, and mostly affecting the worlds poorest population. The …